Thomas G. Burke
- Molecular Biology top 5%
- Oncology top 2%
- Biomaterials top 2%
- Organic Chemistry top 5%
- Pharmacology top 2%
- Co-authors
- Thomas R. TrittonAnna ShenderovaSteven P. SchwendemanDavid BomHenryk MalakRandall E. BolgerW J ChecovichDennis P. Curran
- Topics
- Cancer therapeutics and mechanisms (35 papers)Antibiotics Pharmacokinetics and Efficacy (12 papers)Lipid Membrane Structure and Behavior (11 papers)
- Partner nations
- United StatesFranceDenmark
In The Last Decade
Thomas G. Burke
61 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.5k
- Oncology 1.2k
- Biomaterials 693
- Organic Chemistry 454
- Pharmacology 445
Countries citing papers authored by Thomas G. Burke
This map shows the geographic impact of Thomas G. Burke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Burke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Burke more than expected).
Fields of papers citing papers by Thomas G. Burke
This network shows the impact of papers produced by Thomas G. Burke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Burke. The network helps show where Thomas G. Burke may publish in the future.
Co-authorship network of co-authors of Thomas G. Burke
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Burke. A scholar is included among the top collaborators of Thomas G. Burke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Burke. Thomas G. Burke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 125 | |
| 3 | 26 | |
| 4 | 17 | |
| 5 | 2 | |
| 6 | Camptothecins affinity to HSA and membranes determined by fluorescence anisotropy measurements | 9 |
| 7 | 187 | |
| 8 | 84 | |
| 9 | 5 | |
| 10 | 47 | |
| 11 | 14 | |
| 12 | 151 | |
| 13 | 252 | |
| 14 | 111 | |
| 15 | 66 | |
| 16 | 135 | |
| 17 | 149 | |
| 18 | 80 | |
| 19 | 21 | |
| 20 | 40 |
About Thomas G. Burke
Thomas G. Burke is a scholar working on Biophysics, Oncology and Molecular Biology, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (35 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Lipid Membrane Structure and Behavior (11 papers). The work is most often cited by research in Toxicology (341 citations), Biomaterials (693 citations) and Pharmaceutical Science (265 citations). Thomas G. Burke has collaborated with scholars based in United States, France and Denmark. Frequent co-authors include Thomas R. Tritton, Anna Shenderova, Steven P. Schwendeman, David Bom, Henryk Malak, Randall E. Bolger, W J Checovich, Dennis P. Curran, Monroe E. Wall and Mansukh C. Wani. Their work appears in journals such as Nature, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.